
4 Largecap Stocks With Market Cap of Rs 2-5 Lakh Crore to Watch for Future Multibagger Potential: Sun Pharma, Adani Ports, Titan and M&M
Sun Pharma Rs 1,745.10. Adani Ports Rs 1,748.80. Titan Rs 4,380.90. M&M Rs 2,889. Market caps from Rs 3.48 lakh crore to Rs 4.22 lakh crore. Data as of 21 Oct 2026.
Updated: 22 Oct 2026 • 9:44 am
Posted by:

Quick Answer
Sun Pharma, Adani Ports, Titan and M&M are the 4 picks in this stocks with market cap of Rs 2-5 lakh crore watchlist, with market caps between Rs 3.48 lakh crore and Rs 4.22 lakh crore. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, while Adani Ports offers 26.16% revenue growth in FY26. PE ratios run from 17.19 to 68.51, so compare each one with its industry PE before investing. All figures are as of 21 October 2026.
Stocks with market cap of Rs 2-5 lakh crore to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, Adani Ports, Titan and M&M meet that test, with market caps from Rs 3.48 lakh crore to Rs 4.22 lakh crore and Sun Pharma offering the fastest profit growth, 35.75% a year since FY22. Each of these companies has a market capitalisation between Rs 2,00,000 crore and Rs 5,00,000 crore, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 2,00,000 crore and Rs 5,00,000 crore, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks with market cap of Rs 2-5 lakh crore usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 21 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Stocks With Market Cap of Rs 2-5 Lakh Crore and Why Do They Attract Multibagger Interest?
Stocks with market cap of Rs 2-5 lakh crore are shares of established companies that sit just below the very largest names. The four here cover pharmaceuticals, ports, jewellery and vehicles.
Companies of this size combine stability with a record of consistent growth. For stocks with market cap of Rs 2-5 lakh crore, rising profit adds to the case. Whichever way you read stocks with market cap of Rs 2-5 lakh crore, the common thread is rising profit backed by complete financial data. For stocks with market cap of Rs 2-5 lakh crore, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of stocks with market cap of Rs 2-5 lakh crore, using FY26 and latest quarter data. Prices move daily, so recheck the figures for stocks with market cap of Rs 2-5 lakh crore before you decide.
Stocks With Market Cap of Rs 2-5 Lakh Crore at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 21 October 2026. M&M has the lowest PE of the group at 17.19, while Titan posts the highest return on equity at 32.31%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,745.10 | 4,22,427 | 34.86 | 36.42 | 13.74% | 0.06 | 1,583.70 to 2,046.90 |
| Adani Ports and Special Economic Zone | 1,748.80 | 4,02,686 | 30.69 | 31.83 | 13.32% | 0.66 | 1,292.00 to 1,891.10 |
| Titan Company | 4,380.90 | 3,94,621 | 68.51 | 46.75 | 32.31% | 0.93 | 3,506.50 to 5,186.70 |
| Mahindra & Mahindra | 2,889 | 3,48,064 | 17.19 | 23.82 | 18.37% | 1.44 | 2,744.30 to 3,839.90 |
Sun Pharma: 35.75% Profit CAGR Since FY22
Sun Pharmaceutical Industries is one of India's largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.86 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.
Adani Ports: 26.74% Profit CAGR Since FY22
Adani Ports and Special Economic Zone is India's largest private port operator, with ports on both coasts and a growing logistics business. It reported FY26 revenue of Rs 40,854.36 crore, up 26.16% year on year, and net profit of Rs 12,782.03 crore, up 15.56%. Net profit has compounded at 26.74% a year since FY22, while revenue has grown 20.55% a year. Operating margin was 64.59% in FY26.
The stock trades at a PE of 30.69 against an industry PE of 31.83, below the sector average, with a return on equity of 13.32%. In the June 2026 quarter, revenue rose 23.90% to Rs 11,673.71 crore and net profit grew 10.24% to Rs 3,649.50 crore. The share price has gained 115.30% over five years and 17.95% over the past year. Foreign investors raised their holding from 13.61% in September 2025 to 15.95% in September 2026.
Titan: 23.26% Profit CAGR Since FY22
Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.
In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 72.39% over five years and 22.47% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026. The stock trades at a PE of 68.51 against an industry PE of 46.75, with a return on equity of 32.31%.
M&M: 26.58% Profit CAGR Since FY22
Mahindra & Mahindra is one of the largest SUV makers in India and the country's largest tractor maker, with financial services and electric vehicles in its portfolio. It reported FY26 revenue of Rs 2,02,084.34 crore, up 25.21% year on year, and net profit of Rs 18,621.71 crore, up 32.32%. Net profit has compounded at 26.58% a year since FY22, while revenue has grown 22.04% a year. Operating margin was 21.19% in FY26.
The stock trades at a PE of 17.19 against an industry PE of 23.82, below the sector average, with a return on equity of 18.37%. In the June 2026 quarter, revenue rose 27.47% to Rs 59,203.60 crore and net profit grew 37.04% to Rs 5,997.56 crore. The share price has gained 220.52% over five years. Domestic institutions raised their holding from 29.59% in June 2025 to 32.65% in June 2026.
Stocks With Market Cap of Rs 2-5 Lakh Crore: Financial Comparison on Growth and Margins
The table compares scale and growth across these stocks with market cap of Rs 2-5 lakh crore. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Sun Pharma | 61,673.94 | 11,564.52 | 12.69% | 11.62% | 35.75% | 32.52% |
| Adani Ports | 40,854.36 | 12,782.03 | 26.16% | 20.55% | 26.74% | 65.67% |
| Titan | 88,136 | 5,073 | 44.62% | 32.00% | 23.26% | 14.61% |
| M&M | 2,02,084.34 | 18,621.71 | 25.21% | 22.04% | 26.58% | 20.77% |
Check the Univest Screener for live data on these stocks with market cap of Rs 2-5 lakh crore
Institutional Holding in Sun Pharma, Adani Ports, Titan and M&M
Institutional holding shows who is backing these stocks with market cap of Rs 2-5 lakh crore alongside the promoter. The table uses the latest reported quarter for each. M&M has the deepest institutional backing, with FII and DII together holding 67.54% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), Titan (from 12.78% to 15.34%) and M&M (from 29.59% to 32.65%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Sun Pharma | 52.68% | 14.36% | 22.27% | 10.70% | September 2026 |
| Adani Ports | 66.03% | 15.95% | 13.25% | 4.77% | September 2026 |
| Titan | 52.90% | 15.38% | 15.34% | 16.38% | June 2026 |
| M&M | 18.45% | 34.89% | 32.65% | 14.01% | June 2026 |
Risks to Weigh in Stocks With Market Cap of Rs 2-5 Lakh Crore
Being careful with stocks with market cap of Rs 2-5 lakh crore means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Stocks With Market Cap of Rs 2-5 Lakh Crore
Picking from stocks with market cap of Rs 2-5 lakh crore comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (23.82 to 46.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Sun Pharma, Adani Ports, Titan and M&M live prices.
Conclusion
Among stocks with market cap of Rs 2-5 lakh crore, Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, Adani Ports for 26.16% revenue growth in FY26, Titan for the highest return on equity at 32.31% and M&M for the biggest five-year price gain at 220.52%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks with market cap of Rs 2-5 lakh crore should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Stocks With Market Cap of Rs 2-5 Lakh Crore to Watch
Which are the best stocks with market cap of Rs 2-5 lakh crore to watch for multibagger potential?
Ans. Sun Pharma, Adani Ports, Titan and M&M are the 4 names this list highlights, with market caps of Rs 4,22,427 crore, Rs 4,02,686 crore, Rs 3,94,621 crore and Rs 3,48,064 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Adani Ports stands out for 26.16% revenue growth in FY26. Titan offers the highest return on equity at 32.31%. M&M brings the biggest five-year price gain at 220.52%. These are watchlist names for stocks with market cap of Rs 2-5 lakh crore, not recommendations, so match each one to your own risk profile and time horizon.
Is Titan a good stock for long-term investors?
Ans. Titan has a return on equity of 32.31%, a PE of 68.51 against an industry PE of 46.75 and a market cap of Rs 3,94,621 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in stocks with market cap of Rs 2-5 lakh crore depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Sun Pharma become a multibagger from here?
Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks with market cap of Rs 2-5 lakh crore requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.
What is the market cap of Sun Pharma, Adani Ports, Titan and M&M?
Ans. As of 21 October 2026, Sun Pharma has a market cap of Rs 4,22,427 crore, Adani Ports has a market cap of Rs 4,02,686 crore, Titan has a market cap of Rs 3,94,621 crore and M&M has a market cap of Rs 3,48,064 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with market cap of Rs 2-5 lakh crore.
What are the risks of investing in stocks with market cap of Rs 2-5 lakh crore?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings growth needs to hold up.
Why is Titan trading at a PE of 68.51?
Ans. Titan's PE of 68.51 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in stocks with market cap of Rs 2-5 lakh crore who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Sun Pharma, Adani Ports, Titan and M&M?
Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 29.20% of Adani Ports (15.95% and 13.25%), 30.72% of Titan (15.38% and 15.34%) and 67.54% of M&M (34.89% and 32.65%). Rising institutional holding is a useful signal in stocks with market cap of Rs 2-5 lakh crore, though it should be read with earnings trends rather than on its own.
Recent Articles

4 Largecap Stocks With Price-to-Book Below 4 and Rising Profit to Watch for Future Multibagger Potential: LIC, M&M, NTPC and JSW Steel
22 October 2026

4 Largecap Stocks With 100-150 Per Cent Five-Year Return to Watch for Future Multibagger Potential: L&T, Sun Pharma, Adani Ports and NTPC
22 October 2026

4 Largecap Stocks With Over Rs 1 Lakh Crore Revenue to Watch for Future Multibagger Potential: HDFC Bank, ICICI Bank, SBI and TCS
22 October 2026

4 Largecap Dividend Stocks With 15 Per Cent Profit Growth to Watch for Future Multibagger Potential: LIC, M&M, UltraTech Cement and NTPC
22 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
4 Largecap Stocks With Price-to-Book Below 4 and Rising Profit to Watch for Future Multibagger Potential: LIC, M&M, NTPC and JSW Steel
4 Largecap Stocks With 100-150 Per Cent Five-Year Return to Watch for Future Multibagger Potential: L&T, Sun Pharma, Adani Ports and NTPC
4 Largecap Stocks With Over Rs 1 Lakh Crore Revenue to Watch for Future Multibagger Potential: HDFC Bank, ICICI Bank, SBI and TCS
4 Largecap Dividend Stocks With 15 Per Cent Profit Growth to Watch for Future Multibagger Potential: LIC, M&M, UltraTech Cement and NTPC
4 Largecap Stocks With Net Profit of Rs 10,000-50,000 Crore to Watch for Future Multibagger Potential: TCS, Bajaj Finance, L&T and Infosys
Popular this week
4 Largecap Stocks With Net Profit of Rs 5,000-10,000 Crore to Watch for Future Multibagger Potential: Titan, HAL, UltraTech Cement and Eicher Motors

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





